Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinoma

Eur Urol. 2010 Aug;58(2):307-10. doi: 10.1016/j.eururo.2010.03.005. Epub 2010 Mar 12.

Abstract

A 35-year-old woman presented with a 12-cm right renal mass with retroperitoneal lymph node involvement and pulmonary and bone metastases. Renal mass biopsy revealed an unclassified high-grade non-clear cell renal cell carcinoma (RCC) with eosinophilic cells. Due to the extent of the disease, neoadjuvant temsirolimus was initiated. After 6 wk of treatment, a significant downstaging of the disease and complete disappearance of the metastases were noticed on computed tomography scan. Three months later, a laparoscopic radical nephrectomy and lymphadenectomy was performed. Final pathology confirmed a high-grade non-clear cell RCC, with necrotic changes on lymph node specimens, pT1bN0Mx.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology*
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology*
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use

Substances

  • Antineoplastic Agents
  • temsirolimus
  • Sirolimus